<!DOCTYPE html>
<html lang="en">
<head id="Head1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta http-equiv="content-type" content="text/html;charset=utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=Edge" />
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Full Text of HB3454</title>
    <link rel="shortcut icon" type="image/x-icon" href="https://cdn.ilga.gov/assets/img/site/favicon.ico" />
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap.min.css" />
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <script src="https://cdn.ilga.gov/assets/js/fontawesome/fa.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/jquery.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/js.cookie.min.js"></script>
    <script async src="https://cse.google.com/cse.js?cx=a47f92b5e11c1499a"></script> 
    <!-- Bootstrap Datepicker CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap-datepicker.min.css">
    <!-- Bootstrap Datepicker JavaScript -->
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap-datepicker.min.js"></script>
    <!-- aos, bootstrap icons, swiper CSS -->
    <link href="https://cdn.ilga.gov/assets/css/aos/aos.css" rel="stylesheet">
    <link href="https://cdn.ilga.gov/assets/css/swiper/swiper-bundle.min.css" rel="stylesheet">

    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.js"></script>

    <!-- ILGA main CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/main.css" />
    <link rel="stylesheet" type="text/css" media="print" href="https://cdn.ilga.gov/assets/css/print.css">
    <style></style>
    
</head>
<body>
        <!-- ======= Header ======= -->
        <header id="print-header" class="d-flex align-items-center">
            <div class="container-fluid align-items-center text-uppercase justify-content-start ">
                <div class="logo ">
                    <a href="/"><img src="https://cdn.ilga.gov/assets/img/site/white_capitol.png" alt="ILGA Logo"><span>ILGA.GOV</span></a>
                </div>
                <div class="w-100"></div>
            </div>
        </header>
    <input id="TextSearch" type="hidden" />
    <input id="MobileTextSearch" type="hidden" />
    <input id="message-input" type="hidden" />

    <main id="main-content" role="main">
        <section class="main-page p-2">
	<div class="p-1 pt-4 float-left">
		<div class="row border-bottom pb-3 mb-3">
			<div class="text-start">
				<h2>
					HB3454 - 104th General Assembly
				</h2><br />
			</div>
		</div>
		<div id="content">
			<!-- Full text only shows on large screens -->
			<div class="centered-container d-lg-flex">
				<div class="left-aligned-content">
					<div class="row">
						<div class="col pl-lg-5" translate="no">
							<text class="ml-5 text-left fulltextLineHeight" id="billtextanchor">
								<style>
								
								
								
								table.xsl	{ 	border-collapse: collapse;
												border: 0px solid black;
												font-family: "courier New"; 
												font-size: 10pt;}
								
								td.xsl		{ 	border-collapse: collapse;
												border: 0px solid black;
												padding-top: 3pt;
												padding-bottom: 3pt;
												padding-left: 0pt;
												padding-right: 0pt;
												font-family: "courier New"; 
												font-size: 10pt; }
												
								td.junk		{ 	width: 5%; }
								 
							
					
					
						body.xsl		{ 	text-align:center; }
						
					
						td.lineNum 		{ 	vertical-align: top; 
										  	text-align: right;
										  	font-family: "courier New"; 
										  	font-size: 10pt; }
							
						td.number 		{	width: 5%;
											vertical-align: top; 
										  	text-align: right;
										  	font-family: "Courier New", sans-serif;
										  	font-size: 10pt; }
						
						td.synopsis		{ 	border-collapse: collapse;
											border: 0px solid black;
											padding-top: 0pt;
											padding-bottom: 0pt;
											padding-left: 0pt;
											padding-right: 0pt;
											font-family: "courier New"; 
											font-size: 10pt; }
						
						td.rowsep		{ 	border-bottom: 1px solid black; }
											
						td.colsep		{ 	border-right: 1px solid black; }
											
						td.bothsep		{ 	border-right: 1px solid black;
										  	border-bottom: 1px solid black; }
	
						table.top		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black; }
											
						table.bottom	{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-bottom: 1px solid black; }
											
						table.sides		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black; }
	
						table.all		{ 	font-family: "Courier New", sans-serif;
										  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black;
									  	  	border-bottom: 1px solid black;
									  	  	border-top: 1px solid black; }				
	
						table.topbot	{ 	border-collapse: separate;
									  	  	border: outset 0pt;
										  	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black;
									  	  	border-bottom: 1px solid black; }
					
						.sigline		{ 	text-align: left;
							 		 		vertical-align: bottom;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.siglinetext		{ 	text-align: left;
							 		 		vertical-align: top;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.sigtitle		{ 	text-align: left;
							 				vertical-align: top;
							 				padding: 0pt; }
							 				  
						.sigtitlenum		{ 	text-align: right;
							 				vertical-align: top;
							 				padding: 0pt; }
							
						.siglinenum		{ 	text-align: right;
							 				vertical-align: center;
							 				padding-top: 3pt;
							 				padding: 0pt; }
					</style><table class="xsl" width="578"><pre><tr><td class="xsl" colspan="3"><p> </p><br> </td></tr></td></tr><tr><td class="number"></td><td class="junk"></td><td class="xsl"><table class="xsl" width="100%"><tr><td class="xsl"><center><b><pre><font size="3" face="Courier New">104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026</font><br>HB3454</pre></b></center><p> </p>Introduced 2/18/2025, by Rep. Joyce Mason<p> </p><b>SYNOPSIS AS INTRODUCED:</b><br> </td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><table class="xsl" width="100%"><colgroup width="50%"></colgroup><colgroup width="50%"></colgroup><tr><td class="synopsis"><code>20 ILCS 2610/40</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>50 ILCS 705/10.19</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>105 ILCS 5/22-30</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>215 ILCS 5/356z.33</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>225 ILCS 60/65</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>410 ILCS 27/1</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>410 ILCS 27/5</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>410 ILCS 27/10</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>410 ILCS 27/15</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>410 ILCS 27/20</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>410 ILCS 607/10</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>410 ILCS 620/3.21</code></td><td class="synopsis"><code>  </code><code>from Ch. 56 1/2, par. 503.21</code></td></tr><tr><td class="synopsis"><code>410 ILCS 642/20</code></td><td class="synopsis"></td></tr></table><p></p></td></tr><tr><td class="xsl"><code>    </code><code>Amends various Acts to change references from "epinephrine </code><code>auto-injector" or "epinephrine injector" to "FDA approved epinephrine </code><code>delivery device or product". Changes the name of the Epinephrine Injector </code><code>Act to the FDA Approved Epinephrine Delivery Device or Product Act.</code></td></tr><tr align="right" class="lineNum"><td class="xsl"><br><br></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left"></td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><p> </p><p> </p><center><b>A BILL FOR</b></center><p></p></td></tr></table><p> </p></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>AN ACT concerning health.</code><br> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><b><code>Be it enacted by the People of the State of Illinois, </code></b></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><b><code>represented in the General Assembly:</code></b><br> </td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 5. </code><code>The Illinois State Police Act is amended by </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>changing Section 40 as follows:</code><br> </td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(20 ILCS 2610/40)</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 40. </code><code>Training; administration of epinephrine.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) This Section, along with Section 10.19 of the Illinois </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>Police Training Act, may be referred to as the Annie LeGere </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>Law. </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) For the purposes of this Section, </code><u><code>"FDA approved </code></u></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><u><code>epinephrine delivery device or product"</code></u><code> </code><strike><code>"epinephrine </code></strike></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><strike><code>auto-injector"</code></strike><code> means a single-use device used for the </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>automatic injection of a pre-measured dose of epinephrine into </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>the human body prescribed in the name of the Illinois State </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>Police.</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) The Illinois State Police may conduct or approve a </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>training program for State Police officers to recognize and </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>respond to anaphylaxis, including, but not limited to:</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) how to recognize symptoms of an allergic reaction;</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) how to respond to an emergency involving an </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>allergic reaction;</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) how to administer an </code><u><code>FDA approved epinephrine </code></u></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 2 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <u><code>delivery device or product</code></u><code> </code><strike><code>epinephrine auto-injector</code></strike><code>;</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) how to respond to an individual with a known </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>allergy as well as an individual with a previously unknown </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>allergy;</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) a test demonstrating competency of the knowledge </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>required to recognize anaphylaxis and administer an </code><u><code>FDA </code></u></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <u><code>approved epinephrine delivery device or product</code></u><code> </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <strike><code>epinephrine auto-injector</code></strike><code>; and</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(6) other criteria as determined in rules adopted by </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>the Illinois State Police.</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(d) The Illinois State Police may authorize a State Police </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>officer who has completed the training program under </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>subsection (c) to carry, administer, or assist with the </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>administration of </code><u><code>FDA approved epinephrine delivery devices or </code></u></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><u><code>products</code></u><code> </code><strike><code>epinephrine auto-injectors</code></strike><code> whenever he or she is </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>performing official duties.</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(e) The Illinois State Police must establish a written </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>policy to control the acquisition, storage, transportation, </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>administration, and disposal of </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><u><code>delivery devices or products</code></u><code> </code><strike><code>epinephrine auto-injectors</code></strike><code> before </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>it allows any State Police officer to carry and administer </code><code> </code><u><code>FDA </code></u></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><u><code>approved epinephrine delivery devices or products</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><strike><code>auto-injectors</code></strike><code>.</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(f) A physician, physician assistant with prescriptive </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>authority, or advanced practice registered nurse with </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>prescriptive authority may provide a standing protocol or </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 3 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>prescription for </code><u><code>FDA approved epinephrine delivery devices or </code></u></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><u><code>products</code></u><code> </code><strike><code>epinephrine auto-injectors</code></strike><code> in the name of the </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>Illinois State Police to be maintained for use when necessary.</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(g) When a State Police officer administers an </code><u><code>FDA </code></u></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><u><code>approved epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><strike><code>auto-injector</code></strike><code> in good faith, the officer and the Illinois </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>State Police, and its employees and agents, including a </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>physician, physician assistant with prescriptive authority, or </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>advanced practice registered nurse with prescriptive authority </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>who provides a standing order or prescription for an </code><u><code>FDA </code></u></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><u><code>approved epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><strike><code>auto-injector</code></strike><code>, incur no civil or professional liability, </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>except for willful and wanton conduct, as a result of any </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>injury or death arising from the use of an </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><strike><code>auto-injector</code></strike><code>. </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 102-538, eff. 8-20-21; 102-558, eff. 8-20-21.)</code><br> </td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 10. </code><code>The Illinois Police Training Act is amended by </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>changing Section 10.19 as follows:</code><br> </td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(50 ILCS 705/10.19)</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 10.19. </code><code>Training; administration of epinephrine.</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) This Section, along with Section 40 of the Illinois </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>State Police Act, may be referred to as the Annie LeGere Law. </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) For purposes of this Section, </code><u><code>"FDA approved </code></u></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><u><code>epinephrine delivery device or product"</code></u><code> </code><strike><code>"epinephrine </code></strike></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 4 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><strike><code>auto-injector"</code></strike><code> means a single-use device used for the </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>automatic injection of a pre-measured dose of epinephrine into </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>the human body prescribed in the name of a local law </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>enforcement agency.</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) The Board shall conduct or approve an optional </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>advanced training program for law enforcement officers to </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>recognize and respond to anaphylaxis, including the </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>administration of an </code><u><code>FDA approved epinephrine delivery device </code></u></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><u><code>or product</code></u><code> </code><strike><code>epinephrine auto-injector</code></strike><code>. The training must </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>include, but is not limited to:</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) how to recognize symptoms of an allergic reaction;</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) how to respond to an emergency involving an </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>allergic reaction;</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) how to administer an </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <u><code>delivery device or product</code></u><code> </code><strike><code>epinephrine auto-injector</code></strike><code>;</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) how to respond to an individual with a known </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>allergy as well as an individual with a previously unknown </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>allergy;</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) a test demonstrating competency of the knowledge </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>required to recognize anaphylaxis and administer an </code><u><code>FDA </code></u></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <u><code>approved epinephrine delivery device or product</code></u><code> </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <strike><code>epinephrine auto-injector</code></strike><code>; and</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(6) other criteria as determined in rules adopted by </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>the Board.</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(d) A local law enforcement agency may authorize a law </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>enforcement officer who has completed an optional advanced </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 5 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>training program under subsection (c) to carry, administer, or </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>assist with the administration of </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><u><code>delivery devices or products</code></u><code> </code><strike><code>epinephrine auto-injectors</code></strike><code> </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>provided by the local law enforcement agency whenever the </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>officer is performing official duties.</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(e) A local law enforcement agency that authorizes its </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>officers to carry and administer </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><u><code>delivery devices or products</code></u><code> </code><strike><code>epinephrine auto-injectors</code></strike><code> under </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>subsection (d) must establish a policy to control the </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>acquisition, storage, transportation, administration, and </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>disposal of </code><u><code>FDA approved epinephrine delivery devices or </code></u></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><u><code>products</code></u><code> </code><strike><code>epinephrine auto-injectors</code></strike><code> and to provide continued </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>training in the administration of </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><u><code>delivery devices or products</code></u><code> </code><strike><code>epinephrine auto-injectors</code></strike><code>.</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(f) A physician, physician assistant with prescriptive </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>authority, or advanced practice registered nurse with </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>prescriptive authority may provide a standing protocol or </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>prescription for </code><u><code>FDA approved epinephrine delivery devices or </code></u></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><u><code>products</code></u><code> </code><strike><code>epinephrine auto-injectors</code></strike><code> in the name of a local law </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>enforcement agency to be maintained for use when necessary.</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(g) When a law enforcement officer administers an </code><u><code>FDA </code></u></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><u><code>approved epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><strike><code>auto-injector</code></strike><code> in good faith, the law enforcement officer and </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>local law enforcement agency, and its employees and agents, </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>including a physician, physician assistant with prescriptive </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>authority, or advanced practice registered nurse with </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 6 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>prescriptive authority who provides a standing order or </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>prescription for an </code><u><code>FDA approved epinephrine delivery device </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><u><code>or product</code></u><code> </code><strike><code>epinephrine auto-injector</code></strike><code>, incur no civil or </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>professional liability, except for willful and wanton conduct, </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>or as a result of any injury or death arising from the use of </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>an </code><u><code>FDA approved epinephrine delivery device or product</code></u><code> </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><strike><code>epinephrine auto-injector</code></strike><code>. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 102-538, eff. 8-20-21; 102-694, eff. 1-7-22; </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>103-154, eff. 6-30-23.)</code><br> </td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 15. </code><code>The School Code is amended by changing Section </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>22-30 as follows:</code><br> </td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(105 ILCS 5/22-30)</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 22-30. </code><code>Self-administration and self-carry of asthma </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>medication and </code><u><code>FDA approved epinephrine delivery devices or </code></u></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><u><code>products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code>; administration of undesignated </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><u><code>FDA approved epinephrine delivery devices or products</code></u><code> </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><strike><code>epinephrine injectors</code></strike><code>; administration of an opioid antagonist; </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>administration of undesignated asthma medication; supply of </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>undesignated oxygen tanks; asthma episode emergency response </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>protocol.</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) For the purpose of this Section only, the following </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>terms shall have the meanings set forth below:</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Asthma action plan" means a written plan developed with a </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>pupil's medical provider to help control the pupil's asthma. </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 7 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>The goal of an asthma action plan is to reduce or prevent </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>flare-ups and emergency department visits through day-to-day </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>management and to serve as a student-specific document to be </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>referenced in the event of an asthma episode.</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Asthma episode emergency response protocol" means a </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>procedure to provide assistance to a pupil experiencing </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>symptoms of wheezing, coughing, shortness of breath, chest </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>tightness, or breathing difficulty.</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>"FDA approved epinephrine delivery device or product"</code></u><code> </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><strike><code>"Epinephrine injector"</code></strike><code> includes an auto-injector approved by </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>the United States Food and Drug Administration for the </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>administration of epinephrine and a pre-filled syringe </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>approved by the United States Food and Drug Administration and </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>used for the administration of epinephrine that contains a </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>pre-measured dose of epinephrine that is equivalent to the </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>dosages used in an auto-injector. </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Asthma medication" means quick-relief asthma medication, </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>including albuterol or other short-acting bronchodilators, </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>that is approved by the United States Food and Drug </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>Administration for the treatment of respiratory distress. </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>"Asthma medication" includes medication delivered through a </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>device, including a metered dose inhaler with a reusable or </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>disposable spacer or a nebulizer with a mouthpiece or mask.</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Opioid antagonist" means a drug that binds to opioid </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>receptors and blocks or inhibits the effect of opioids acting </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>on those receptors, including, but not limited to, naloxone </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 8 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>hydrochloride or any other similarly acting drug approved by </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>the U.S. Food and Drug Administration. </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Respiratory distress" means the perceived or actual </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>presence of wheezing, coughing, shortness of breath, chest </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>tightness, breathing difficulty, or any other symptoms </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>consistent with asthma. Respiratory distress may be </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>categorized as "mild-to-moderate" or "severe". </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"School nurse" means a registered nurse working in a </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>school with or without licensure endorsed in school nursing. </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Self-administration" means a pupil's discretionary use of </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>his or her prescribed asthma medication or </code><u><code>FDA approved </code></u></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><u><code>epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code>.</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Self-carry" means a pupil's ability to carry his or her </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>prescribed asthma medication or </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><u><code>delivery device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code>.</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Standing protocol" may be issued by (i) a physician </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>licensed to practice medicine in all its branches, (ii) a </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>licensed physician assistant with prescriptive authority, or </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>(iii) a licensed advanced practice registered nurse with </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>prescriptive authority. </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Trained personnel" means any school employee or volunteer </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>personnel authorized in Sections 10-22.34, 10-22.34a, and </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>10-22.34b of this Code who has completed training under </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>subsection (g) of this Section to recognize and respond to </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>anaphylaxis, an opioid overdose, or respiratory distress.</code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Undesignated asthma medication" means asthma medication </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 9 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>prescribed in the name of a school district, public school, </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>charter school, or nonpublic school.</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Undesignated </code><u><code>FDA approved epinephrine delivery device or </code></u></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><u><code>product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code>" means an </code><u><code>FDA approved </code></u></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><u><code>epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code> </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>prescribed in the name of a school district, public school, </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>charter school, or nonpublic school. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) A school, whether public, charter, or nonpublic, must </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>permit the self-administration and self-carry of asthma </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>medication by a pupil with asthma or the self-administration </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>and self-carry of an </code><u><code>FDA approved epinephrine delivery device </code></u></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><u><code>or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code> by a pupil, provided that:</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) the parents or guardians of the pupil provide to </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>the school (i) written authorization from the parents or </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>guardians for (A) the self-administration and self-carry </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>of asthma medication or (B) the self-carry of asthma </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>medication or (ii) for (A) the self-administration and </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>self-carry of an </code><u><code>FDA approved epinephrine delivery device </code></u></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <u><code>or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code> or (B) the self-carry of </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>an </code><u><code>FDA approved epinephrine delivery device or product</code></u><code> </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <strike><code>epinephrine injector</code></strike><code>, written authorization from the </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>pupil's physician, physician assistant, or advanced </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>practice registered nurse; and</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) the parents or guardians of the pupil provide to </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>the school (i) the prescription label, which must contain </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>the name of the asthma medication, the prescribed dosage, </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 10 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>and the time at which or circumstances under which the </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>asthma medication is to be administered, or (ii) for the </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>self-administration or self-carry of an </code><u><code>FDA approved </code></u></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <u><code>epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <strike><code>injector</code></strike><code>, a written statement from the pupil's physician, </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>physician assistant, or advanced practice registered nurse </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>containing the following information:</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(A) the name and purpose of the </code><u><code>FDA approved </code></u></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >        <u><code>epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >        <strike><code>injector</code></strike><code>;</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(B) the prescribed dosage; and</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(C) the time or times at which or the special </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >        <code>circumstances under which the </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >        <u><code>delivery device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code> is to </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >        <code>be administered.</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>The information provided shall be kept on file in the office of </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>the school nurse or, in the absence of a school nurse, the </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>school's administrator.</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b-5) A school district, public school, charter school, or </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>nonpublic school may authorize the provision of a </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>student-specific or undesignated </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><u><code>delivery device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code> to a student </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>or any personnel authorized under a student's Individual </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>Health Care Action Plan, allergy emergency action plan, or </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>plan pursuant to Section 504 of the federal Rehabilitation Act </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>of 1973 to administer an </code><u><code>FDA approved epinephrine delivery </code></u></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 11 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><u><code>device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code> to the student, that </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>meets the student's prescription on file.</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b-10) The school district, public school, charter school, </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>or nonpublic school may authorize a school nurse or trained </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>personnel to do the following: (i) provide an undesignated </code><u><code>FDA </code></u></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><u><code>approved epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><strike><code>injector</code></strike><code> to a student for self-administration only or any </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>personnel authorized under a student's Individual Health Care </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>Action Plan, allergy emergency action plan, plan pursuant to </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>Section 504 of the federal Rehabilitation Act of 1973, or </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>individualized education program plan to administer to the </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>student that meets the student's prescription on file; (ii) </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>administer an undesignated </code><u><code>FDA approved epinephrine delivery </code></u></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><u><code>device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code> that meets the </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>prescription on file to any student who has an Individual </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>Health Care Action Plan, allergy emergency action plan, plan </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>pursuant to Section 504 of the federal Rehabilitation Act of </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>1973, or individualized education program plan that authorizes </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>the use of an </code><u><code>FDA approved epinephrine delivery device or </code></u></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><u><code>product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code>; (iii) administer an undesignated </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><u><code>FDA approved epinephrine delivery device or product</code></u><code> </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><strike><code>epinephrine injector</code></strike><code> to any person that the school nurse or </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>trained personnel in good faith believes is having an </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>anaphylactic reaction; (iv) administer an opioid antagonist to </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>any person that the school nurse or trained personnel in good </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>faith believes is having an opioid overdose; (v) provide </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 12 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>undesignated asthma medication to a student for </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>self-administration only or to any personnel authorized under </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>a student's Individual Health Care Action Plan or asthma </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>action plan, plan pursuant to Section 504 of the federal </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>Rehabilitation Act of 1973, or individualized education </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>program plan to administer to the student that meets the </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>student's prescription on file; (vi) administer undesignated </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>asthma medication that meets the prescription on file to any </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>student who has an Individual Health Care Action Plan or </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>asthma action plan, plan pursuant to Section 504 of the </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>federal Rehabilitation Act of 1973, or individualized </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>education program plan that authorizes the use of asthma </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>medication; and (vii) administer undesignated asthma </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>medication to any person that the school nurse or trained </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>personnel believes in good faith is having respiratory </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>distress. </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) The school district, public school, charter school, or </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>nonpublic school must inform the parents or guardians of the </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>pupil, in writing, that the school district, public school, </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>charter school, or nonpublic school and its employees and </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>agents, including a physician, physician assistant, or </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>advanced practice registered nurse providing standing protocol </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>and a prescription for school </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><u><code>delivery devices or products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code>, an opioid </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>antagonist, or undesignated asthma medication, are to incur no </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>liability or professional discipline, except for willful and </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 13 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>wanton conduct, as a result of any injury arising from the </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>administration of asthma medication, an </code><u><code>FDA approved </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><u><code>epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code>, </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>or an opioid antagonist regardless of whether authorization </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>was given by the pupil's parents or guardians or by the pupil's </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>physician, physician assistant, or advanced practice </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>registered nurse. The parents or guardians of the pupil must </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>sign a statement acknowledging that the school district, </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>public school, charter school, or nonpublic school and its </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>employees and agents are to incur no liability, except for </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>willful and wanton conduct, as a result of any injury arising </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>from the administration of asthma medication, an </code><u><code>FDA approved </code></u></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><u><code>epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code>, </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>or an opioid antagonist regardless of whether authorization </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>was given by the pupil's parents or guardians or by the pupil's </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>physician, physician assistant, or advanced practice </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>registered nurse and that the parents or guardians must </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>indemnify and hold harmless the school district, public </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>school, charter school, or nonpublic school and its employees </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>and agents against any claims, except a claim based on willful </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>and wanton conduct, arising out of the administration of </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>asthma medication, an </code><u><code>FDA approved epinephrine delivery device </code></u></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><u><code>or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code>, or an opioid antagonist </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>regardless of whether authorization was given by the pupil's </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>parents or guardians or by the pupil's physician, physician </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>assistant, or advanced practice registered nurse.</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 14 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c-5) When a school nurse or trained personnel administers </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>an undesignated </code><u><code>FDA approved epinephrine delivery device or </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><u><code>product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code> to a person whom the school nurse </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>or trained personnel in good faith believes is having an </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>anaphylactic reaction, administers an opioid antagonist to a </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>person whom the school nurse or trained personnel in good </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>faith believes is having an opioid overdose, or administers </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>undesignated asthma medication to a person whom the school </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>nurse or trained personnel in good faith believes is having </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>respiratory distress, notwithstanding the lack of notice to </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>the parents or guardians of the pupil or the absence of the </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>parents or guardians signed statement acknowledging no </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>liability, except for willful and wanton conduct, the school </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>district, public school, charter school, or nonpublic school </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>and its employees and agents, and a physician, a physician </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>assistant, or an advanced practice registered nurse providing </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>standing protocol and a prescription for undesignated </code><u><code>FDA </code></u></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><u><code>approved epinephrine delivery devices or products</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><strike><code>injectors</code></strike><code>, an opioid antagonist, or undesignated asthma </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>medication, are to incur no liability or professional </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>discipline, except for willful and wanton conduct, as a result </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>of any injury arising from the use of an undesignated </code><u><code>FDA </code></u></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><u><code>approved epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><strike><code>injector</code></strike><code>, the use of an opioid antagonist, or the use of </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>undesignated asthma medication, regardless of whether </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>authorization was given by the pupil's parents or guardians or </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 15 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>by the pupil's physician, physician assistant, or advanced </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>practice registered nurse.</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(d) The permission for self-administration and self-carry </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>of asthma medication or the self-administration and self-carry </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>of an </code><u><code>FDA approved epinephrine delivery device or product</code></u><code> </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><strike><code>epinephrine injector</code></strike><code> is effective for the school year for </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>which it is granted and shall be renewed each subsequent </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>school year upon fulfillment of the requirements of this </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>Section.</code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(e) Provided that the requirements of this Section are </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>fulfilled, a pupil with asthma may self-administer and </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>self-carry his or her asthma medication or a pupil may </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>self-administer and self-carry an </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><u><code>delivery device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code> (i) while in </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>school, (ii) while at a school-sponsored activity, (iii) while </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>under the supervision of school personnel, or (iv) before or </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>after normal school activities, such as while in before-school </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>or after-school care on school-operated property or while </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>being transported on a school bus.</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(e-5) Provided that the requirements of this Section are </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>fulfilled, a school nurse or trained personnel may administer </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>an undesignated </code><u><code>FDA approved epinephrine delivery device or </code></u></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><u><code>product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code> to any person whom the school </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>nurse or trained personnel in good faith believes to be having </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>an anaphylactic reaction (i) while in school, (ii) while at a </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>school-sponsored activity, (iii) while under the supervision </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 16 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>of school personnel, or (iv) before or after normal school </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>activities, such as while in before-school or after-school </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>care on school-operated property or while being transported on </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>a school bus. A school nurse or trained personnel may carry </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>undesignated </code><u><code>FDA approved epinephrine delivery devices or </code></u></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><u><code>products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code> on his or her person while in </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>school or at a school-sponsored activity. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(e-10) Provided that the requirements of this Section are </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>fulfilled, a school nurse or trained personnel may administer </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>an opioid antagonist to any person whom the school nurse or </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>trained personnel in good faith believes to be having an </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>opioid overdose (i) while in school, (ii) while at a </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>school-sponsored activity, (iii) while under the supervision </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>of school personnel, or (iv) before or after normal school </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>activities, such as while in before-school or after-school </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>care on school-operated property. A school nurse or trained </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>personnel may carry an opioid antagonist on his or her person </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>while in school or at a school-sponsored activity. </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(e-15) If the requirements of this Section are met, a </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>school nurse or trained personnel may administer undesignated </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>asthma medication to any person whom the school nurse or </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>trained personnel in good faith believes to be experiencing </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>respiratory distress (i) while in school, (ii) while at a </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>school-sponsored activity, (iii) while under the supervision </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>of school personnel, or (iv) before or after normal school </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>activities, including before-school or after-school care on </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 17 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>school-operated property. A school nurse or trained personnel </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>may carry undesignated asthma medication on his or her person </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>while in school or at a school-sponsored activity. </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(f) The school district, public school, charter school, or </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>nonpublic school may maintain a supply of undesignated </code><u><code>FDA </code></u></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><u><code>approved epinephrine delivery devices or products</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><strike><code>injectors</code></strike><code> in any secure location that is accessible before, </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>during, and after school where an allergic person is most at </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>risk, including, but not limited to, classrooms and </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>lunchrooms. A physician, a physician assistant who has </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>prescriptive authority in accordance with Section 7.5 of the </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>Physician Assistant Practice Act of 1987, or an advanced </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>practice registered nurse who has prescriptive authority in </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>accordance with Section 65-40 of the Nurse Practice Act may </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>prescribe undesignated </code><u><code>FDA approved epinephrine delivery </code></u></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><u><code>devices or products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code> in the name of the </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>school district, public school, charter school, or nonpublic </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>school to be maintained for use when necessary. Any supply of </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><u><code>FDA approved epinephrine delivery devices or products</code></u><code> </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><strike><code>epinephrine injectors</code></strike><code> shall be maintained in accordance with </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>the manufacturer's instructions.</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>The school district, public school, charter school, or </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>nonpublic school shall maintain a supply of an opioid </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>antagonist in any secure location where an individual may have </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>an opioid overdose, unless there is a shortage of opioid </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>antagonists, in which case the school district, public school, </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 18 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>charter school, or nonpublic school shall make a reasonable </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>effort to maintain a supply of an opioid antagonist. Unless </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>the school district, public school, charter school, or </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>nonpublic school is able to obtain opioid antagonists without </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>a prescription, a health care professional who has been </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>delegated prescriptive authority for opioid antagonists in </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>accordance with Section 5-23 of the Substance Use Disorder Act </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>shall prescribe opioid antagonists in the name of the school </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>district, public school, charter school, or nonpublic school, </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>to be maintained for use when necessary. Any supply of opioid </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>antagonists shall be maintained in accordance with the </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>manufacturer's instructions. </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>The school district, public school, charter school, or </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>nonpublic school may maintain a supply of asthma medication in </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>any secure location that is accessible before, during, or </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>after school where a person is most at risk, including, but not </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>limited to, a classroom or the nurse's office. A physician, a </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>physician assistant who has prescriptive authority under </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>Section 7.5 of the Physician Assistant Practice Act of 1987, </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>or an advanced practice registered nurse who has prescriptive </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>authority under Section 65-40 of the Nurse Practice Act may </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>prescribe undesignated asthma medication in the name of the </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>school district, public school, charter school, or nonpublic </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>school to be maintained for use when necessary. Any supply of </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>undesignated asthma medication must be maintained in </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>accordance with the manufacturer's instructions. </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 19 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>A school district that provides special educational </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>facilities for children with disabilities under Section </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>14-4.01 of this Code may maintain a supply of undesignated </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>oxygen tanks in any secure location that is accessible before, </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>during, and after school where a person with developmental </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>disabilities is most at risk, including, but not limited to, </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>classrooms and lunchrooms. A physician, a physician assistant </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>who has prescriptive authority in accordance with Section 7.5 </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>of the Physician Assistant Practice Act of 1987, or an </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>advanced practice registered nurse who has prescriptive </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>authority in accordance with Section 65-40 of the Nurse </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>Practice Act may prescribe undesignated oxygen tanks in the </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>name of the school district that provides special educational </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>facilities for children with disabilities under Section </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>14-4.01 of this Code to be maintained for use when necessary. </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>Any supply of oxygen tanks shall be maintained in accordance </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>with the manufacturer's instructions and with the local fire </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>department's rules. </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(f-3) Whichever entity initiates the process of obtaining </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>undesignated </code><u><code>FDA approved epinephrine delivery devices or </code></u></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><u><code>products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code> and providing training to </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>personnel for carrying and administering undesignated </code><u><code>FDA </code></u></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><u><code>approved epinephrine delivery devices or products</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><strike><code>injectors</code></strike><code> shall pay for the costs of the undesignated </code><u><code>FDA </code></u></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><u><code>approved epinephrine delivery devices or products</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><strike><code>injectors</code></strike><code>.</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 20 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(f-5) Upon any administration of an </code><u><code>FDA approved </code></u></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><u><code>epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code>, a </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>school district, public school, charter school, or nonpublic </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>school must immediately activate the EMS system and notify the </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>student's parent, guardian, or emergency contact, if known.</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Upon any administration of an opioid antagonist, a school </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>district, public school, charter school, or nonpublic school </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>must immediately activate the EMS system and notify the </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>student's parent, guardian, or emergency contact, if known. </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(f-10) Within 24 hours of the administration of an </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>undesignated </code><u><code>FDA approved epinephrine delivery device or </code></u></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><u><code>product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code>, a school district, public </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>school, charter school, or nonpublic school must notify the </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>physician, physician assistant, or advanced practice </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>registered nurse who provided the standing protocol and a </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>prescription for the undesignated </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><u><code>delivery device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code> of its use. </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Within 24 hours after the administration of an opioid </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>antagonist, a school district, public school, charter school, </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>or nonpublic school must notify the health care professional </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>who provided the prescription for the opioid antagonist of its </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>use. </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Within 24 hours after the administration of undesignated </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>asthma medication, a school district, public school, charter </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>school, or nonpublic school must notify the student's parent </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>or guardian or emergency contact, if known, and the physician, </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 21 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>physician assistant, or advanced practice registered nurse who </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>provided the standing protocol and a prescription for the </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>undesignated asthma medication of its use. The district or </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>school must follow up with the school nurse, if available, and </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>may, with the consent of the child's parent or guardian, </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>notify the child's health care provider of record, as </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>determined under this Section, of its use. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(g) Prior to the administration of an undesignated </code><u><code>FDA </code></u></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><u><code>approved epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><strike><code>injector</code></strike><code>, trained personnel must submit to the school's </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>administration proof of completion of a training curriculum to </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>recognize and respond to anaphylaxis that meets the </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>requirements of subsection (h) of this Section. Training must </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>be completed annually. The school district, public school, </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>charter school, or nonpublic school must maintain records </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>related to the training curriculum and trained personnel.</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Prior to the administration of an opioid antagonist, </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>trained personnel must submit to the school's administration </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>proof of completion of a training curriculum to recognize and </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>respond to an opioid overdose, which curriculum must meet the </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>requirements of subsection (h-5) of this Section. The school </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>district, public school, charter school, or nonpublic school </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>must maintain records relating to the training curriculum and </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>the trained personnel. </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Prior to the administration of undesignated asthma </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>medication, trained personnel must submit to the school's </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 22 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>administration proof of completion of a training curriculum to </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>recognize and respond to respiratory distress, which must meet </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>the requirements of subsection (h-10) of this Section. </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>Training must be completed annually, and the school district, </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>public school, charter school, or nonpublic school must </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>maintain records relating to the training curriculum and the </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>trained personnel. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(h) A training curriculum to recognize and respond to </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>anaphylaxis, including the administration of an undesignated </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><u><code>FDA approved epinephrine delivery device or product</code></u><code> </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><strike><code>epinephrine injector</code></strike><code>, may be conducted online or in person.</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Training shall include, but is not limited to:</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) how to recognize signs and symptoms of an allergic </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>reaction, including anaphylaxis;</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) how to administer an </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <u><code>delivery device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code>; and</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) a test demonstrating competency of the knowledge </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>required to recognize anaphylaxis and administer an </code><u><code>FDA </code></u></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <u><code>approved epinephrine delivery device or product</code></u><code> </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <strike><code>epinephrine injector</code></strike><code>.</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Training may also include, but is not limited to:</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(A) a review of high-risk areas within a school and </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>its related facilities;</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(B) steps to take to prevent exposure to allergens;</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(C) emergency follow-up procedures, including the </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>importance of calling 9-1-1 or, if 9-1-1 is not available, </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 23 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>other local emergency medical services;</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(D) how to respond to a student with a known allergy, </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>as well as a student with a previously unknown allergy;</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(E) other criteria as determined in rules adopted </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>pursuant to this Section; and</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(F) any policy developed by the State Board of </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>Education under Section 2-3.190.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>In consultation with statewide professional organizations </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>representing physicians licensed to practice medicine in all </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>of its branches, registered nurses, and school nurses, the </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>State Board of Education shall make available resource </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>materials consistent with criteria in this subsection (h) for </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>educating trained personnel to recognize and respond to </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>anaphylaxis. The State Board may take into consideration the </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>curriculum on this subject developed by other states, as well </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>as any other curricular materials suggested by medical experts </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>and other groups that work on life-threatening allergy issues. </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>The State Board is not required to create new resource </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>materials. The State Board shall make these resource materials </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>available on its Internet website.</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(h-5) A training curriculum to recognize and respond to an </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>opioid overdose, including the administration of an opioid </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>antagonist, may be conducted online or in person. The training </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>must comply with any training requirements under Section 5-23 </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>of the Substance Use Disorder Act and the corresponding rules. </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>It must include, but is not limited to:</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 24 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) how to recognize symptoms of an opioid overdose;</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) information on drug overdose prevention and </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>recognition;</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) how to perform rescue breathing and resuscitation;</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) how to respond to an emergency involving an opioid </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>overdose;</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) opioid antagonist dosage and administration;</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(6) the importance of calling 9-1-1 or, if 9-1-1 is </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>not available, other local emergency medical services;</code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(7) care for the overdose victim after administration </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>of the overdose antagonist;</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(8) a test demonstrating competency of the knowledge </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>required to recognize an opioid overdose and administer a </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>dose of an opioid antagonist; and</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(9) other criteria as determined in rules adopted </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>pursuant to this Section. </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(h-10) A training curriculum to recognize and respond to </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>respiratory distress, including the administration of </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>undesignated asthma medication, may be conducted online or in </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>person. The training must include, but is not limited to:</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) how to recognize symptoms of respiratory distress </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>and how to distinguish respiratory distress from </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>anaphylaxis;</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) how to respond to an emergency involving </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>respiratory distress;</code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) asthma medication dosage and administration;</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 25 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) the importance of calling 9-1-1 or, if 9-1-1 is </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>not available, other local emergency medical services;</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) a test demonstrating competency of the knowledge </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>required to recognize respiratory distress and administer </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>asthma medication; and</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(6) other criteria as determined in rules adopted </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>under this Section. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(i) Within 3 days after the administration of an </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>undesignated </code><u><code>FDA approved epinephrine delivery device or </code></u></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><u><code>product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code> by a school nurse, trained </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>personnel, or a student at a school or school-sponsored </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>activity, the school must report to the State Board of </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>Education in a form and manner prescribed by the State Board </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>the following information:</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) age and type of person receiving epinephrine </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>(student, staff, visitor);</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) any previously known diagnosis of a severe </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>allergy;</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) trigger that precipitated allergic episode;</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) location where symptoms developed;</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) number of doses administered;</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(6) type of person administering epinephrine (school </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>nurse, trained personnel, student); and</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(7) any other information required by the State Board.</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>If a school district, public school, charter school, or </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>nonpublic school maintains or has an independent contractor </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 26 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>providing transportation to students who maintains a supply of </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>undesignated </code><u><code>FDA approved epinephrine delivery devices or </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><u><code>products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code>, then the school district, </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>public school, charter school, or nonpublic school must report </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>that information to the State Board of Education upon adoption </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>or change of the policy of the school district, public school, </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>charter school, nonpublic school, or independent contractor, </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>in a manner as prescribed by the State Board. The report must </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>include the number of undesignated </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><u><code>delivery device or product</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code> in supply.</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(i-5) Within 3 days after the administration of an opioid </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>antagonist by a school nurse or trained personnel, the school </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>must report to the State Board of Education, in a form and </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>manner prescribed by the State Board, the following </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>information:</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) the age and type of person receiving the opioid </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>antagonist (student, staff, or visitor);</code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) the location where symptoms developed;</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) the type of person administering the opioid </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>antagonist (school nurse or trained personnel); and</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) any other information required by the State Board. </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(i-10) Within 3 days after the administration of </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>undesignated asthma medication by a school nurse, trained </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>personnel, or a student at a school or school-sponsored </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>activity, the school must report to the State Board of </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>Education, on a form and in a manner prescribed by the State </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 27 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>Board of Education, the following information:</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) the age and type of person receiving the asthma </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>medication (student, staff, or visitor);</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) any previously known diagnosis of asthma for the </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>person;</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) the trigger that precipitated respiratory </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>distress, if identifiable;</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) the location of where the symptoms developed;</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) the number of doses administered;</code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(6) the type of person administering the asthma </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>medication (school nurse, trained personnel, or student);</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(7) the outcome of the asthma medication </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>administration; and</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(8) any other information required by the State Board. </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(j) By October 1, 2015 and every year thereafter, the </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>State Board of Education shall submit a report to the General </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>Assembly identifying the frequency and circumstances of </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>undesignated epinephrine and undesignated asthma medication </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>administration during the preceding academic year. Beginning </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>with the 2017 report, the report shall also contain </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>information on which school districts, public schools, charter </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>schools, and nonpublic schools maintain or have independent </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>contractors providing transportation to students who maintain </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>a supply of undesignated </code><u><code>FDA approved epinephrine delivery </code></u></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><u><code>devices or products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code>. This report shall </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>be published on the State Board's Internet website on the date </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 28 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>the report is delivered to the General Assembly.</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(j-5) Annually, each school district, public school, </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>charter school, or nonpublic school shall request an asthma </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>action plan from the parents or guardians of a pupil with </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>asthma. If provided, the asthma action plan must be kept on </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>file in the office of the school nurse or, in the absence of a </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>school nurse, the school administrator. Copies of the asthma </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>action plan may be distributed to appropriate school staff who </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>interact with the pupil on a regular basis, and, if </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>applicable, may be attached to the pupil's federal Section 504 </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>plan or individualized education program plan.</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(j-10) To assist schools with emergency response </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>procedures for asthma, the State Board of Education, in </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>consultation with statewide professional organizations with </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>expertise in asthma management and a statewide organization </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>representing school administrators, shall develop a model </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>asthma episode emergency response protocol before September 1, </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>2016. Each school district, charter school, and nonpublic </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>school shall adopt an asthma episode emergency response </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>protocol before January 1, 2017 that includes all of the </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>components of the State Board's model protocol.</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(j-15) (Blank).</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(j-20) On or before October 1, 2016 and every year </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>thereafter, the State Board of Education shall submit a report </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>to the General Assembly and the Department of Public Health </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>identifying the frequency and circumstances of opioid </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 29 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>antagonist administration during the preceding academic year. </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>This report shall be published on the State Board's Internet </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>website on the date the report is delivered to the General </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>Assembly. </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(k) The State Board of Education may adopt rules necessary </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>to implement this Section. </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(l) Nothing in this Section shall limit the amount of </code><u><code>FDA </code></u></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><u><code>approved epinephrine delivery devices or products</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><strike><code>injectors</code></strike><code> that any type of school or student may carry or </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>maintain a supply of.</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 102-413, eff. 8-20-21; 102-813, eff. 5-13-22; </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>103-175, eff. 6-30-23; 103-196, eff. 1-1-24; 103-348, eff. </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>1-1-24; 103-542, eff. 7-1-24 (see Section 905 of P.A. 103-563 </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>for effective date of P.A. 103-542); 103-605, eff. 7-1-24.)</code><br> </td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 20. </code><code>The Illinois Insurance Code is amended by </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>changing Section 356z.33 as follows:</code><br> </td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(215 ILCS 5/356z.33)</code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 356z.33. </code><code>Coverage for </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><u><code>delivery devices or products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code>. </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) A group or individual policy of accident and health </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>insurance or a managed care plan that is amended, delivered, </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>issued, or renewed on or after January 1, 2020 (the effective </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>date of Public Act 101-281) shall provide coverage for </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>medically necessary </code><u><code>FDA approved epinephrine delivery devices </code></u></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 30 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><u><code>or products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code> for persons 18 years of age </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>or under. As used in this Section, </code><u><code>"FDA approved epinephrine </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><u><code>delivery device or product"</code></u><code> </code><strike><code>"epinephrine injector"</code></strike><code> has the </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>meaning given to that term in Section 5 of the </code><u><code>FDA Approved </code></u></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><u><code>Epinephrine Delivery Device or Product</code></u><code> </code><strike><code>Epinephrine Injector</code></strike><code> </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>Act.</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) An insurer that provides coverage for medically </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>necessary </code><u><code>FDA approved epinephrine delivery devices or </code></u></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><u><code>products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code> shall limit the total amount </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>that an insured is required to pay for a twin-pack of medically </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>necessary </code><u><code>FDA approved epinephrine delivery devices or </code></u></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><u><code>products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code> at an amount not to exceed $60, </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>regardless of the type of </code><u><code>FDA approved epinephrine delivery </code></u></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><u><code>device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code>; except that this </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>provision does not apply to the extent such coverage would </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>disqualify a high-deductible health plan from eligibility for </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>a health savings account pursuant to Section 223 of the </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>Internal Revenue Code (26 U.S.C. 223).</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) Nothing in this Section prevents an insurer from </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>reducing an insured's cost sharing by an amount greater than </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>the amount specified in subsection (b).</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(d) The Department may adopt rules as necessary to </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>implement and administer this Section. </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 102-558, eff. 8-20-21; 103-454, eff. 1-1-25; </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>103-718, eff. 7-19-24</code><code>.)</code><br> </td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 31 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 25. </code><code>The Medical Practice Act of 1987 is amended by </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>changing Section 65 as follows:</code><br> </td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(225 ILCS 60/65)</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(Section scheduled to be repealed on January 1, 2027)</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 65. </code><code>Annie LeGere Law; </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><u><code>delivery device or product</code></u><code> </code><strike><code>epinephrine auto-injector</code></strike><code>. </code><code>A </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>licensee under this Act may not be subject to discipline for </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>providing a standing order or prescription for an </code><u><code>FDA approved </code></u></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><u><code>epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><strike><code>auto-injector</code></strike><code> in accordance with Section 40 of the Illinois </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>State Police Act or Section 10.19 of the Illinois Police </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>Training Act.</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 102-538, eff. 8-20-21.)</code><br> </td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 30. </code><code>The Epinephrine Injector Act is amended by </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>changing Sections 1, 5, 10, 15, and 20 as follows:</code><br> </td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(410 ILCS 27/1)</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 1. </code><code>Short title. </code><code>This Act may be cited as the </code><u><code>FDA </code></u></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><u><code>Approved Epinephrine Delivery Device or Product</code></u><code> </code><strike><code>Epinephrine </code></strike></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><strike><code>Injector</code></strike><code> Act.</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19</code><code>.)</code><br> </td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(410 ILCS 27/5)</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 5. </code><code>Definitions. </code><code>As used in this Act:</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 32 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Administer" means to directly apply an epinephrine </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>injector to the body of an individual.</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Authorized entity" means any entity or organization, </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>other than a school covered under Section 22-30 of the School </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>Code, in connection with or at which allergens capable of </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>causing anaphylaxis may be present, including, but not limited </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>to, independent contractors who provide student transportation </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>to schools, recreation camps, colleges and universities, day </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>care facilities, youth sports leagues, amusement parks, </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>restaurants, sports arenas, and places of employment. The </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>Department shall, by rule, determine what constitutes a day </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>care facility under this definition.</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Department" means the Department of Public Health.</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>"FDA approved epinephrine delivery device or product"</code></u><code> </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><strike><code>"Epinephrine injector"</code></strike><code> includes an auto-injector approved by </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>the United States Food and Drug Administration for the </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>administration of epinephrine and a pre-filled syringe </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>approved by the United States Food and Drug Administration and </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>used for the administration of epinephrine that contains a </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>pre-measured dose of epinephrine that is equivalent to the </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>dosages used in an auto-injector. </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Health care practitioner" means a physician licensed to </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>practice medicine in all its branches under the Medical </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>Practice Act of 1987, a physician assistant under the </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>Physician Assistant Practice Act of 1987 with prescriptive </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>authority, or an advanced practice registered nurse with </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 33 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>prescribing authority under Article 65 of the Nurse Practice </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>Act.</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Pharmacist" has the meaning given to that term under </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>subsection (k-5) of Section 3 of the Pharmacy Practice Act.</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Undesignated </code><u><code>FDA approved epinephrine delivery device or </code></u></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><u><code>product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code>" means an </code><u><code>FDA approved </code></u></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><u><code>epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code> </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>prescribed in the name of an authorized entity.</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 99-711, eff. 1-1-17; 100-513, eff. 1-1-18; </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>100-799, eff. 1-1-19</code><code>.)</code><br> </td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(410 ILCS 27/10)</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 10. </code><code>Prescription to authorized entity; use; training.</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) A health care practitioner may prescribe </code><u><code>FDA approved </code></u></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><u><code>epinephrine delivery devices or products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code> </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>in the name of an authorized entity for use in accordance with </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>this Act, and pharmacists and health care practitioners may </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>dispense </code><u><code>FDA approved epinephrine delivery devices or products</code></u><code> </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><strike><code>epinephrine injectors</code></strike><code> pursuant to a prescription issued in the </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>name of an authorized entity. Such prescriptions shall be </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>valid for a period of 2 years.</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) An authorized entity may acquire and stock a supply of </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>undesignated </code><u><code>FDA approved epinephrine delivery devices or </code></u></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><u><code>products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code> pursuant to a prescription </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>issued under subsection (a) of this Section. Such undesignated </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><u><code>FDA approved epinephrine delivery devices or products</code></u><code> </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 34 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><strike><code>epinephrine injectors</code></strike><code> shall be stored in a location readily </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>accessible in an emergency and in accordance with the </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>instructions for use of the </code><u><code>FDA approved epinephrine delivery </code></u></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><u><code>devices or products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code>. The Department may </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>establish any additional requirements an authorized entity </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>must follow under this Act.</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) An employee or agent of an authorized entity or other </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>individual who has completed training under subsection (d) of </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>this Section may:</code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) provide an </code><u><code>FDA approved epinephrine delivery </code></u></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <u><code>device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code> to any individual </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>on the property of the authorized entity whom the </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>employee, agent, or other individual believes in good </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>faith is experiencing anaphylaxis, or to the parent, </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>guardian, or caregiver of such individual, for immediate </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>administration, regardless of whether the individual has a </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>prescription for an </code><u><code>FDA approved epinephrine delivery </code></u></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <u><code>device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code> or has previously </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>been diagnosed with an allergy; or</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) administer an </code><u><code>FDA approved epinephrine delivery </code></u></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <u><code>device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code> to any individual </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>on the property of the authorized entity whom the </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>employee, agent, or other individual believes in good </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>faith is experiencing anaphylaxis, regardless of whether </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>the individual has a prescription for an </code><u><code>FDA approved </code></u></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <u><code>epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 35 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <strike><code>injector</code></strike><code> or has previously been diagnosed with an allergy.</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(d) An employee, agent, or other individual authorized </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>must complete an anaphylaxis training program before he or she </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>is able to provide or administer an </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><u><code>delivery device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code> under this </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>Section. Such training shall be valid for a period of 2 years </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>and shall be conducted by a nationally recognized organization </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>experienced in training laypersons in emergency health </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>treatment. The Department shall include links to training </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>providers' websites on its website.</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Training shall include, but is not limited to:</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) how to recognize signs and symptoms of an allergic </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>reaction, including anaphylaxis;</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) how to administer an </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <u><code>delivery device or product</code></u><code> </code><strike><code>epinephrine injector</code></strike><code>; and</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) a test demonstrating competency of the knowledge </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>required to recognize anaphylaxis and administer an </code><u><code>FDA </code></u></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <u><code>approved epinephrine delivery device or product</code></u><code> </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <strike><code>epinephrine injector</code></strike><code>.</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Training may also include, but is not limited to:</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(A) a review of high-risk areas on the authorized </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>entity's property and its related facilities;</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(B) steps to take to prevent exposure to allergens;</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(C) emergency follow-up procedures; and</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(D) other criteria as determined in rules adopted </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>pursuant to this Act.</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 36 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Training may be conducted either online or in person. The </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>Department shall approve training programs and list permitted </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>training programs on the Department's Internet website.</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19</code><code>.)</code><br> </td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(410 ILCS 27/15)</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 15. </code><code>Costs. </code><code>Whichever entity initiates the process of </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>obtaining undesignated </code><u><code>FDA approved epinephrine delivery </code></u></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><u><code>devices or products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code> and providing </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>training to personnel for carrying and administering </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>undesignated </code><u><code>FDA approved epinephrine delivery devices or </code></u></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><u><code>products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code> shall pay for the costs of the </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>undesignated </code><u><code>FDA approved epinephrine delivery devices or </code></u></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><u><code>products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code>.</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19</code><code>.)</code><br> </td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(410 ILCS 27/20)</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 20. </code><code>Limitations. </code><code>The use of an undesignated </code><u><code>FDA </code></u></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><u><code>approved epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><strike><code>injector</code></strike><code> in accordance with the requirements of this Act does </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>not constitute the practice of medicine or any other </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>profession that requires medical licensure.</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Nothing in this Act shall limit the amount of </code><u><code>FDA approved </code></u></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><u><code>epinephrine delivery devices or products</code></u><code> </code><strike><code>epinephrine injectors</code></strike><code> </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>that an authorized entity or individual may carry or maintain </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>a supply of.</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 37 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19</code><code>.)</code><br> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 35. </code><code>The Emergency Asthma Inhalers and Allergy </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>Treatment for Children Act is amended by changing Section 10 </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>as follows:</code><br> </td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(410 ILCS 607/10)</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 10. </code><code>Possession, self-administration, and use of </code><u><code>FDA </code></u></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><u><code>approved epinephrine delivery devices or products</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><strike><code>auto-injectors</code></strike><code> or inhalers at recreation camps and </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>after-school care programs. </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) A recreation camp or an after-school care program </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>shall permit a child with severe, potentially life-threatening </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>allergies to possess, self-administer, and use an </code><u><code>FDA approved </code></u></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><u><code>epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><strike><code>auto-injector</code></strike><code> or inhaler, if the following conditions are </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>satisfied:</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) The child has the written approval of his or her </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>parent or guardian.</code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) The recreational camp or after-school care program </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>administrator or, if a nurse is assigned to the camp or </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>program, the nurse shall receive copies of the written </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>approvals required under paragraph (1) of subsection (a) </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>of this Section.</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) The child's parent or guardian shall submit </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>written verification confirming that the child has the </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 38 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>knowledge and skills to safely possess, self-administer, </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>and use an </code><u><code>FDA approved epinephrine delivery device or </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <u><code>product</code></u><code> </code><strike><code>epinephrine auto-injector</code></strike><code> or inhaler in a camp or </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>an after-school care program setting.</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) The child's parent or guardian shall provide the camp </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>or program with the following information:</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) the child's name;</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) the name, route, and dosage of medication;</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) the frequency and time of medication </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>administration or assistance;</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) the date of the order;</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) a diagnosis and any other medical conditions </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>requiring medications, if not a violation of </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>confidentiality or if not contrary to the request of the </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>parent or guardian to keep confidential;</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(6) specific recommendations for administration;</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(7) any special side effects, contraindications, and </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>adverse reactions to be observed;</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(8) the name of each required medication; and </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(9) any severe adverse reactions that may occur to </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>another child, for whom the </code><u><code>FDA approved epinephrine </code></u></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <u><code>delivery device or product</code></u><code> </code><strike><code>epinephrine auto-injector</code></strike><code> or </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>inhaler is not prescribed, should the other child receive </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>a dose of the medication.</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) If the conditions of this Act are satisfied, the child </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>may possess, self-administer, and use an </code><u><code>FDA approved </code></u></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 39 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><u><code>epinephrine delivery device or product</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><strike><code>auto-injector</code></strike><code> or inhaler at the camp or after-school care </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>program or at any camp-sponsored or program-sponsored </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>activity, event, or program.</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(d) The recreational camp or after-school care program </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>must inform the parents or guardians of the child, in writing, </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>that the recreational camp or after-school care program and </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>its employees and agents are to incur no liability, as </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>applicable, except for willful and wanton conduct, as a result </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>of any injury arising from the self-administration of </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>medication to the child. The parents or guardians of the child </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>must sign a statement acknowledging that the recreational camp </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>or after-school care program is to incur no liability, except </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>for willful and wanton conduct, as a result of any injury </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>arising from the self-administration of medication by the </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>child and that the parents or guardians must indemnify and </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>hold harmless the recreational camp or after-school care </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>program and its employees and agents, as applicable, against </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>any claims, except a claim based on willful and wanton </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>conduct, arising out of the self-administration of medication </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>by the child.</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(e) After-school care program personnel who have completed </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>an anaphylaxis training program as identified under the </code><u><code>FDA </code></u></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><u><code>Approved Epinephrine Delivery Device or Product</code></u><code> </code><strike><code>Epinephrine </code></strike></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><strike><code>Injector</code></strike><code> Act may administer an undesignated epinephrine </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>injection to any child if the after-school care program </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 40 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>personnel believe in good faith that the child is having an </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>anaphylactic reaction while in the after-school care program. </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>After-school care program personnel may carry undesignated </code><u><code>FDA </code></u></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><u><code>approved epinephrine delivery devices or products</code></u><code> </code><strike><code>epinephrine </code></strike></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><strike><code>injectors</code></strike><code> on their person while in the after-school care </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>program.</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(f) After-school care program personnel may administer </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>undesignated asthma medication to any child if the </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>after-school care program personnel believe in good faith that </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>the child is experiencing respiratory distress while in the </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>after-school care program. After-school care program personnel </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>may carry undesignated asthma medication on their person while </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>in the after-school care program.</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(g) If after-school care program personnel are to </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>administer an undesignated epinephrine injection or an </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>undesignated asthma medication to a child, the after-school </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>care program personnel must inform the parents or guardians of </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>the child, in writing, that the after-school care program and </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>its employees and agents, acting in accordance with standard </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>protocols and the prescription for the injection or </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>medication, shall incur no liability, except for willful and </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>wanton conduct, as a result of any injury arising from the </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>administration of the injection or medication, notwithstanding </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>whether authorization was given by the child's parents or </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>guardians or by the child's physician, physician assistant, or </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>advanced practice registered nurse. A parent or guardian of </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 41 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>the child must sign a statement acknowledging that the </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>after-school care program and its employees and agents are to </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>incur no liability, except for willful and wanton conduct, as </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>a result of any injury arising from the administration of the </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>medication or injection, regardless of whether authorization </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>was given by a parent or guardian of the child or by the </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>child's physician, physician assistant, or advanced practice </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>registered nurse, and that the parent or guardian must also </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>indemnify and hold harmless the after-school care program and </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>its employees and agents against any claims, except a claim </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>based on willful and wanton conduct, arising out of the </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>administration of the medication or injection, regardless of </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>whether authorization was given by the child's parent or </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>guardian or by the child's physician, physician assistant, or </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>advanced practice registered nurse.</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(h) If after-school care program personnel administer an </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>undesignated epinephrine injection to a person and the </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>after-school care program personnel believe in good faith the </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>person is having an anaphylactic reaction or administer </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>undesignated asthma medication to a person and believe in good </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>faith the person is experiencing respiratory distress, then </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>the after-school care program and its employees and agents, </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>acting in accordance with standard protocols and the </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>prescription for the injection or medication, shall not incur </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>any liability or be subject to professional discipline, except </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>for willful and wanton conduct, as a result of any injury </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 42 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>arising from the use of the injection or medication, </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>notwithstanding whether notice was given to or authorization </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>was given by the child's parent or guardian or by the child's </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>physician, physician assistant, or advanced practice </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>registered nurse and notwithstanding the absence of the </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>parent's or guardian's signed statement acknowledging release </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>from liability.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(i) The changes made to this Section by this amendatory </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>Act of the 103rd General Assembly apply to actions filed on or </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>after the effective date of this amendatory Act of the 103rd </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>General Assembly. </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 103-438, eff. 8-4-23.)</code><br> </td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 40. </code><code>The Illinois Food, Drug and Cosmetic Act is </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>amended by changing Section 3.21 as follows:</code><br> </td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(410 ILCS 620/3.21)</code><code>  </code><code>(from Ch. 56 1/2, par. 503.21)</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 3.21. </code><code>Except as authorized by this Act, the Illinois </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>Controlled Substances Act, the Pharmacy Practice Act, the </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>Dental Practice Act, the Medical Practice Act of 1987, the </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>Veterinary Medicine and Surgery Practice Act of 2004, the </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>Podiatric Medical Practice Act of 1987, Section 22-30 of the </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>School Code, Section 40 of the Illinois State Police Act, </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>Section 10.19 of the Illinois Police Training Act, or the </code><u><code>FDA </code></u></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><u><code>Approved Epinephrine Delivery Device or Product</code></u><code> </code><strike><code>Epinephrine </code></strike></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><strike><code>Injector</code></strike><code> Act, to sell or dispense a prescription drug without </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 43 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>a prescription.</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 102-538, eff. 8-20-21.)</code><br> </td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 45. </code><code>The Home Health and Hospice Drug Dispensation </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>and Administration Act is amended by changing Section 20 as </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>follows:</code><br> </td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(410 ILCS 642/20)</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 20. </code><code>Possession of specified drugs. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) A home health agency, hospice, or authorized nursing </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>employee of an agency or hospice, in compliance with this </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>Section, may possess or transport the following specified </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>drugs in a sealed portable container for the purpose of </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>administration to the agency's or hospice's patients pursuant </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>to the patient's treating health care professional's orders: </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) Sterile saline in a sealed portable container of a </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>size determined by the dispensing pharmacist.</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) Sterile water.</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) Not more than 5 dosage units of any of the </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>following items in an individually sealed, unused portable </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>container: </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(A) Heparin sodium lock flush in a concentration </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >        <code>of 10 units per milliliter or 100 units per </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >        <code>milliliter.</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(B) Epinephrine HCI solution in a concentration of </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >        <code>one to 1,000. </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3454</td><td class="xsl" align="center">- 44 -</td><td class="xsl" align="right">LRB104 09749 BDA 19815 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) Not more than 2 dosage units of Diphenhydramine </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>(Benadryl) 50 milligrams intravenously in an individually </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>sealed, unused portable container, clearly labeled, and </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>placed in a protective carrier.</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 94-638, eff. 8-22-05.)</code></pre></table>
							</text>
						</div>
					</div>
				</div>
			</div>
		</div>
    </div>
</section>
    </main>
    <!-- Vendor JS Files -->
    <script src="https://cdn.ilga.gov/assets/js/aos/aos.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/popper.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap.bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/glightbox/glightbox.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/swiper/swiper-bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/main.js"></script>

    

</body>
</html>
